Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Vincristine for Group B Intraocular Retinoblastoma
NCT00079417Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Dec 2005
- Primary completion
- Jan 2010
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, vincristine sulfate liposome injection in retinoblastoma (Rb), sponsored by Children's Oncology Group. Started Dec 2005; status: completed.
02
Drugs
carboplatinvincristine sulfate liposome injection
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT00079417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079417.